Haemoglobin, C‐reactive protein and androgen levels in uncomplicated and complicated pregnancies of women with polycystic ovary syndrome

References

• Asuncion M., Calvo R. M., San Millan J. L., Sancho J., Avila S., Escobar‐Morreale H. F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434–8
   PubMed Web of Science ®Google Scholar
• Balen A. H., Tan S. L., MacDougall J., Jacobs H. S. Miscarriage rates following in‐vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum Reprod 1993; 8: 959–64
   PubMed Web of Science ®Google Scholar
• Clifford K., Rai R., Watson H., Regan L. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod 1994; 9: 1328–32
   PubMed Web of Science ®Google Scholar
• Homburg R., Armar N. A., Eshel A., Adams J., Jacobs H. S. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988; 297: 1024–6
   PubMed Web of Science ®Google Scholar
• Tulppala M., Stenman U. H., Cacciatore B., Ylikorkala O. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol 1993; 100: 348–52
   PubMedGoogle Scholar
• Bjercke S., Dale P. O., Tanbo T., Storeng R., Ertzeid G., Abyholm T. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 2002; 54: 94–8
   PubMed Web of Science ®Google Scholar
• de Vries M. J., Dekker G. A., Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998; 76: 91–5
   PubMed Web of Science ®Google Scholar
• Diamant Y. Z., Rimon E., Evron S. High incidence of preeclamptic toxemia in patients with polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 1982; 14: 199–204
   PubMed Web of Science ®Google Scholar
• Gjonnaess H. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome: the influence of body‐weight. Br J Obstet Gynaecol 1989; 96: 714–19
   PubMedGoogle Scholar
• Mikola M., Hiilesmaa V., Halttunen M., Suhonen L., Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001; 16: 226–9
   PubMed Web of Science ®Google Scholar
• Radon P. A., McMahon M. J., Meyer W. R. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94: 194–7
   PubMed Web of Science ®Google Scholar
• Boomsma C. M., Eijkemans M. J., Hughes E. G., Visser G. H., Fauser B. C., Macklon N. S. A meta‐analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006; 12: 673–83
   PubMed Web of Science ®Google Scholar
• Sir‐Petermann T., Maliqueo M., Angel B., Lara H. E., Perez‐Bravo F., Recabarren S. E. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002; 17: 2573–9
   PubMed Web of Science ®Google Scholar
• Carlsen S. M., Romundstad P., Jacobsen G. Early second trimester hyperandrogenemia and subsequent preeclampsia: a prospective study. Acta Obstet Gynecol Scand 2004; 84: 117–21
   Web of Science ®Google Scholar
• Serin I. S., Kula M., Basbug M., Unluhizarci K., Gucer S., Tayyar M. Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery. Acta Obstet Gynecol Scand 2001; 80: 1009–13
   PubMed Web of Science ®Google Scholar
• Steier J. A., Ulstein M., Myking O. L. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstet Gynecol 2002; 100: 552–6
   PubMed Web of Science ®Google Scholar
• Troisi R., Potischman N., Roberts J. M., et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003; 32: 455–60
   PubMed Web of Science ®Google Scholar
• Laivuori H., Kaaja R., Rutanen E. M., Viinikka L., Ylikorkala O. Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab 1998; 83: 344–7
   PubMed Web of Science ®Google Scholar
• Vanky E., Salvesen K. A., Heimstad R., Fougner K. J., Romundstad P., Carlsen S. M. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study. Hum Reprod 2004; 19: 1734–40
   PubMed Web of Science ®Google Scholar
• Consensus. Revised 2003 consensus on diagnostic criteria and long‐term health risks related to polycystic ovary syndrome (PCOS)., Hum Reprod. 19. 41–7
   Google Scholar
• Expert committee. Report of the expert committee on diagnosis and classification of diabetes mellitus., Diabetes Care. S5–19
   Google Scholar
• Koller O., Sandvei R., Sagen N. High hemoglobin levels during pregnancy and fetal risk. Int J Gynaecol Obstet 1980; 18: 53–6
   PubMedGoogle Scholar
• Murphy J. F., O'Riordan J., Newcombe R. G., Coles E. C., Pearson J. F. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. Lancet 1986; 1: 992–5
   PubMed Web of Science ®Google Scholar
• Steer P., Alam M. A., Wadsworth J., Welch A. Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. Br Med J 1995; 310: 489–91
   PubMed Web of Science ®Google Scholar
• Hvilsom G. B., Thorsen P., Jeune B., Bakketeig L. S. C‐reactive protein: a serological marker for preterm delivery?. Acta Obstet Gynecol Scand 2002; 81: 424–9
   PubMed Web of Science ®Google Scholar
• Retnakaran R., Hanley A. J., Raif N., Connelly P. W., Sermer M., Zinman B. C‐reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003; 88: 3507–12
   PubMed Web of Science ®Google Scholar
• Paternoster D. M., Fantinato S., Stella A., et al. C‐reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost 2006; 12: 330–7
   PubMed Web of Science ®Google Scholar
• Lohsoonthorn V., Qiu C., Williams M. A. Maternal serum C‐reactive protein concentrations in early pregnancy and subsequent risk of preterm delivery. Clin Biochem 2007; 40: 330–5
   PubMed Web of Science ®Google Scholar
• Ferraz T. B., Motta R. S., Ferraz C. L., Capibaribe D. M., Forti A. C., Chacra A. R. C‐reactive protein and features of metabolic syndrome in Brazilian women with previous gestational diabetes. Diabetes Res Clin Pract 2007; 78: 23–9
   PubMed Web of Science ®Google Scholar
• Hahnel M. E., Martin J. D., Michael C. A., Hahnel R. Metabolism of androstenedione by placental microsomes in pregnancy hypertension. Clin Chim Acta 1989; 181: 103–8
   PubMed Web of Science ®Google Scholar